Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia
Conditions:   Antiphospholipid Syndrome;   Thrombocytopenia;   Treatment Intervention:   Drug: zanubrutinib Sponsor:   Zhang Lei Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 20, 2022 Category: Research Source Type: clinical trials

Effectivity and Safety of Different Anticoagulants in Patients With Thromboembolic Antiphospholipid Syndrome
Conditions:   Antiphospholipid Syndrome;   Venous Thromboembolism;   Arterial Thromboembolism;   Major Bleed Intervention:   Sponsor:   Cardioangiologisches Centrum Bethanien Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2022 Category: Research Source Type: clinical trials

Impact of Antiphospholipid Antibodies on Thrombin Generation During Sars-CoV2 Infection (TACIT2 Study)
Conditions:   Antiphospholipid Syndrome;   COVID-19 Intervention:   Diagnostic Test: characterization of aPL Sponsor:   Central Hospital, Nancy, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2021 Category: Research Source Type: clinical trials